Search Login Register

Wasting Syndrome (Wasting Disease) Summary

Description: A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism.

Also Known As: Wasting Disease; Wasting Diseases; Wasting Syndromes

Networked: 640 relevant articles (13 outcomes, 51 trials/studies) for this Disease

Key Drugs and Agents for Wasting Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tetrachlorodibenzodioxin (TCDD) : 2 outcomes 4 studies in 54 results : IBA
  2. Formaldehyde (Formol) : 1 outcome 3 studies in 14 results : FDA 1
  3. Paraffin : 1 outcome 3 studies in 12 results : IBA
  4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 1 outcome 2 studies in 14 results : IBA
  5. Magnesium : 1 outcome 1 study in 6 results : IBA
  6. Prednisone (Sone) : 1 outcome 1 study in 3 results : FDA 119 Generic
  7. thymosin fraction 5 : 1 outcome 1 study in 2 results : IBA
  8. Sodium : 1 outcome in 29 results : IBA
  9. Steroids : 1 outcome in 7 results : IBA
  10. Cytochrome P-450 CYP1A1 (CYP1A1) : 1 outcome in 4 results : IBA
Show All >>

Diseases Related to Wasting Syndrome

  1. Neoplasms (Cancer)
  2. Acquired Immunodeficiency Syndrome (AIDS)
  3. Hyponatremia
  4. Inappropriate ADH Syndrome (SIADH)
  5. Cachexia
Show All >>

Key Therapies for Wasting Syndrome

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome 1 study in 14 results
  2. Transplants (Transplant) : 1 study in 15 results
  3. Thymectomy : 1 study in 13 results
  4. Highly Active Antiretroviral Therapy (HAART) : 1 study in 9 results
  5. Intensive Care (Surgical Intensive Care) : 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.